- conflicts or gaps
- [[{"field": "founders", "conflict": "YC and TechCrunch list three co-founders (Gupta, Kallenbach, Duffy); Forbes 30 Under 30 and some databases list only Gupta and Kallenbach.", "source_urls": ["https://www.ycombinator.com/companies/reverie-labs", "https://techcrunch.com/2018/03/16/reverie-labs-uses-new-machine-learning-algorithms-to-fix-drug-development-bottlenecks/", "https://www.forbes.com/profile/reverie-labs/", "https://tracxn.com/d/companies/reverielabs/__KK9JD-uznpt71zyBuf4NJTLFLkO2_5-bi3zK_PZZf_k"]}, {"field": "funding.total_raised_usd", "conflict": "Company press release and Forbes cite >$32M; Tracxn reports $32M in 2 rounds; CB Insights reports $25.15M across 10 rounds; The Company Check reports $25.03M across 2 rounds.", "source_urls": ["https://www.prnewswire.com/news-releases/reverie-labs-raises-25m-series-a-round-to-broaden-impact-of-its-computational-kinase-drug-discovery-platform-301220854.html", "https://www.forbes.com/profile/reverie-labs/", "https://tracxn.com/d/companies/reverielabs/__KK9JD-uznpt71zyBuf4NJTLFLkO2_5-bi3zK_PZZf_k/funding-and-investors", "https://www.cbinsights.com/company/reverie-labs/financials", "https://www.thecompanycheck.com/company/b/reverie-labs/t5mdwe2feebvr33bk"]}, {"field": "employees.headcount", "conflict": "YC lists 29; The Company Check lists 27 (Dec 2022); Ankit Gupta LinkedIn cites ~30; YCDB lists 10 (stale); LinkedIn company page shows 1 post-acquisition.", "source_urls": ["https://www.ycombinator.com/companies/reverie-labs", "https://www.thecompanycheck.com/company/b/reverie-labs/t5mdwe2feebvr33bk", "https://www.linkedin.com/in/ankitvgupta", "https://www.ycdb.co/company/reverie-labs", "https://www.linkedin.com/company/reverie-labs"]}, {"field": "identity.headquarters", "conflict": "Most primary sources say Cambridge, MA; YCDB lists Boston, MA; TechCrunch 2018 article says Boston-based.", "source_urls": ["https://www.ycombinator.com/companies/reverie-labs", "https://www.ycdb.co/company/reverie-labs", "https://techcrunch.com/2018/03/16/reverie-labs-uses-new-machine-learning-algorithms-to-fix-drug-development-bottlenecks/"]}, {"field": "exit_status.purchase_price_usd", "conflict": "Total acquisition price undisclosed; only $3.53M RSU inducements publicly disclosed; full cash/stock consideration unknown.", "source_urls": ["https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-reverie-labs-platform-enhancing-ai-driven-drug-discovery-capabilities-for-customer-programs-302073641.html", "https://www.prnewswire.com/news-releases/ginkgo-bioworks-provides-compensation-information-related-to-recent-acquisitions-302073672.html", "https://www.fiercebiotech.com/medtech/ginkgo-go-go-bioworks-company-forges-3-acquisition-deals"]}, {"field": "products.pipeline_post_acquisition_fate", "conflict": "RVL-101/102/103 and Roche-partnered assets had preclinical progress, but Ginkgo deal language covers AI platform assets only; pipeline ownership/fate not publicly confirmed.", "source_urls": ["https://www.boringbusinessnerd.com/startups/reverie-labs", "https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-reverie-labs-platform-enhancing-ai-driven-drug-discovery-capabilities-for-customer-programs-302073641.html", "https://delta.larvol.com/Products/?ProductId=950f2d0a-7b10-4314-ae41-d8646a09763e"]}, {"field": "funding.rounds", "conflict": "2018 seed and 2020 ~$6.6M round amounts/dates inconsistently tracked across databases; several intermediate rounds lack disclosed amounts in primary sources.", "source_urls": ["https://www.cbinsights.com/company/reverie-labs/financials", "https://www.forbes.com/sites/johncumbers/2020/08/25/a-virtual-drug-discovery-company-with-no-lab-of-its-own-partners-with-roche-to-fight-cancers-in-the-brain/", "https://startups.rip/company/reverie-labs"]}, {"field": "founders.connor_duffy.tenure", "conflict": "Duffy listed as YC founder but LinkedIn shows Reverie tenure Sep 2017–Sep 2018 only; long-term operating leadership was Gupta and Kallenbach.", "source_urls": ["https://www.ycombinator.com/companies/reverie-labs", "https://linkedin.com/in/cvduffy"]}, {"field": "exit_status.deal_type", "conflict": "Described as acquisition of key assets and acqui-hire of four employees; CEO Jonah Kallenbach did not join Ginkgo; independent Reverie entity status post-deal unclear.", "source_urls": ["https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-reverie-labs-platform-enhancing-ai-driven-drug-discovery-capabilities-for-customer-programs-302073641.html", "https://www.linkedin.com/posts/jonah-kallenbach_acquiring-reverie-labs-platform-to-enhance-activity-7168598301821370368-kujq"]}, {"field": "products.pipeline", "conflict": "RVL program stages sourced mainly from secondary databases and pre-acquisition trackers; no first-party Reverie press release names RVL-101/102/103.", "source_urls": ["https://www.boringbusinessnerd.com/startups/reverie-labs", "https://workinbiotech.com/companies/reverie-labs", "https://www.prnewswire.com/news-releases/reverie-labs-raises-25m-series-a-round-to-broaden-impact-of-its-computational-kinase-drug-discovery-platform-301220854.html"]}]]
- source urls
- ["https://delta.larvol.com/Products/?ProductId=950f2d0a-7b10-4314-ae41-d8646a09763e", "https://entrepreneurship.mit.edu/news/11-student-founded-companies-backed-rdv-2017/", "https://linkedin.com/in/cvduffy", "https://startups.rip/company/reverie-labs", "https://synapse.patsnap.com/drug/b3b5709953124f7cbf7f02769501d4f6", "https://synapse.patsnap.com/organization/08e8e52485893a5c97e886e51822ea00", "https://techcrunch.com/2018/03/16/reverie-labs-uses-new-machine-learning-algorithms-to-fix-drug-development-bottlenecks/", "https://tracxn.com/d/companies/reverielabs/__KK9JD-uznpt71zyBuf4NJTLFLkO2_5-bi3zK_PZZf_k", "https://tracxn.com/d/companies/reverielabs/__KK9JD-uznpt71zyBuf4NJTLFLkO2_5-bi3zK_PZZf_k/funding-and-investors", "https://venturebeat.com/business/reverie-labs-raises-25-million-for-its-ai-drug-discovery-platform/", "https://workinbiotech.com/companies/reverie-labs", "https://www.boringbusinessnerd.com/startups/reverie-labs", "https://www.cbinsights.com/company/reverie-labs/financials", "https://www.fiercebiotech.com/medtech/ginkgo-go-go-bioworks-company-forges-3-acquisition-deals", "https://www.forbes.com/profile/reverie-labs/", "https://www.forbes.com/sites/johncumbers/2020/08/25/a-virtual-drug-discovery-company-with-no-lab-of-its-own-partners-with-roche-to-fight-cancers-in-the-brain/", "https://www.linkedin.com/company/reverie-labs", "https://www.linkedin.com/in/ankitvgupta", "https://www.linkedin.com/posts/jonah-kallenbach_acquiring-reverie-labs-platform-to-enhance-activity-7168598301821370368-kujq", "https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-reverie-labs-platform-enhancing-ai-driven-drug-discovery-capabilities-for-customer-programs-302073641.html", "https://www.prnewswire.com/news-releases/ginkgo-bioworks-provides-compensation-information-related-to-recent-acquisitions-302073672.html", "https://www.prnewswire.com/news-releases/reverie-labs-enters-multi-target-collaboration-agreement-with-roche-301089930.html", "https://www.prnewswire.com/news-releases/reverie-labs-raises-25m-series-a-round-to-broaden-impact-of-its-computational-kinase-drug-discovery-platform-301220854.html", "https://www.reverielabs.com/", "https://www.roche.com/stories/harnessing-the-power-of-ai", "https://www.synbiobeta.com/read/a-virtual-drug-discovery-company-with-no-lab-of-its-own-partners-with-roche-to-fight-cancers-in-the-brain", "https://www.thecompanycheck.com/company/b/reverie-labs/t5mdwe2feebvr33bk", "https://www.ycdb.co/company/reverie-labs", "https://www.ycombinator.com/companies/reverie-labs"]